Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina
Research output: Contribution to journal › Journal article › Research › peer-review
We evaluated the feasibility, safety and efficacy of intra-myocardial injection of autologous mesenchymal stromal cells derived endothelial progenitor cell (MSC) in patients with stable coronary artery disease (CAD) and refractory angina in this first in man trial.
| Original language | English |
|---|---|
| Journal | Scandinavian Cardiovascular Journal |
| Volume | 45 |
| Issue number | 3 |
| Pages (from-to) | 161-8 |
| Number of pages | 8 |
| ISSN | 1401-7431 |
| DOIs | |
| Publication status | Published - Jun 2011 |
| Externally published | Yes |
- Aged, Angina Pectoris, Coronary Artery Disease, Feasibility Studies, Female, Follow-Up Studies, Humans, Injections, Intramuscular, Male, Mesenchymal Stem Cell Transplantation, Middle Aged, Severity of Illness Index, Transplantation, Autologous, Treatment Outcome
Research areas
ID: 47741472